ABSTRACT: High quality nanocrystals have demonstrated substantial potential for biomedical applications. However, being generally hydrophobic, their use has been greatly limited by complicated and inefficient surface engineering that often fails to yield biocompatible nanocrystals with minimal aggregation in biological fluids and active targeting toward specific biomolecules. Using chimeric DNA molecules, we developed a one-step facile surface engineering method for hydrophobic nanocrystals. The procedure is simple and versatile, generating individual nanocrystals with multiple ligands. In addition, the resulting nanocrystals can actively and specifically target various molecular addresses, varying from nucleic acids to cancer cells. Together, the strategy developed here holds great promise in generating critical technologies needed for biomedical applications of nanocrystals.
N anometer-scale crystallites, which possess unique size-or shape-dependent physical and chemical properties, have demonstrated substantial potential for biomedical applications, including molecular imaging, 1,2 disease diagnostics, 3, 4 cancer therapy, 5−7 etc. For example, quantum dots (QDs) have been used to sensitize photodynamic therapy (PDT) agents, leading to a novel class of PDT sensitizers with tunable optical properties for treating both shallow-and deep-seated tumors. 8 However, high quality nanocrystals are typically synthesized in organic solvents at elevated temperatures, resulting in bioincompatible nanocrystals coated with hydrophobic surfactant stabilizers (such as oleylamine, oleic acid, and any other hydrocarbon chaincontaining ligands). 9, 10 To address this issue, two major strategies have been devised for hydrophobic nanocrystal surface engineering to generate soluble and stable nanocrystals in aqueous solutions: (1) ligand exchange with thiol-, phosphine-, or dopamine-containing molecules and (2) ligand encapsulation by a layer of amphiphilic polymers or silica shell. 11−13 Unfortunately, despite recent advances, these surface engineering approaches often fail to produce individually dispersed nanocrystals in various biological fluids. In addition, complicated procedures and intensive energy input (e.g., heat and sonication) are generally required.
14 Most importantly, additional steps are needed to incorporate biological moieties for specific molecular recognition, making the entire process time-and laborconsuming.
Here, we demonstrate a novel one-step method for hydrophobic nanocrystal surface engineering to produce different types of water-soluble nanocrystals with tunable molecular recognition, using chimeric DNA molecules containing both hydrophobic (diacyllipid) and hydrophilic (oligonucleotide) parts. Through hydrophobic interactions, whereby relatively apolar molecules aggregate in aqueous solutions, 15 these chimeric DNA molecules spontaneously intercalate in the surfactant layer of hydrophobic nanocrystals using their hydrophobic parts, encapsulating an individual nanocrystal inside the diacyllipid core and leaving an oligonucleotide corona outside (Scheme 1). The resulting water-soluble nanocrystals have a relatively narrow hydrodynamic size distribution and longterm stability in various biological media. In addition, since DNA can specifically recognize their targets by either Watson−Crick base pairing or by folding into distinct tertiary structures, these functionalized nanocrystals possess excellent selectivity to a variety of biomolecular targets, varying from nucleic acids to cancer cells.
The chimeric DNA molecules are synthesized by efficiently incorporating a diacyllipid at the 5′ end of oligonucleotides through solid phase DNA synthesis on a fully automated DNA/ RNA synthesizer, according to our previously reported procedure. 16, 17 To test the feasibility of this facile surface engineering method, oleylamine-coated Fe−Fe 3 O 4 core−shell nanoparticles (CSNPs) (13 nm CSNPs was 25 μM. On average, there were 48 chimeric DNA molecules per modified nanoparticle at that concentration. In order to obtain functionalized nanoparticles with the desired solubility in aqueous environments, enough chimeric DNA molecules were needed; Fe−Fe 3 O 4 CSNPs modified with adequate chimeric DNA molecules (≥10 μM) are soluble upon adding water, whereas the ones engineered with insufficient ligands (≤5 μM) need vigorous vortexing or even sonication ( Figure S5 , SI). In addition, chimeric DNA molecules with varying lengths (from 5 to 60 nt) and distinct sequence information were all found to generate functionalized nanoparticles with excellent water dispersity ( Figure S6, SI) . Moreover, the hydrodynamic diameter and zeta-potential of modified nanoparticles increased with the length of chimeric DNA molecules (Table S2, SI) .
Since this novel surface engineering approach does not rely on the properties of the nanocrystal core or the reactivity of the nanocrystal surface, it could be generalized for many hydrophobic nanocrystals with variable size, composition, and morphology. To verify this point, chimeric DNA molecules were used to engineer Fe 3 O 4 nanoparticles (NPs) with two different sizes (7 and 15 nm diameter). Water-soluble Fe 3 O 4 NPs with minimal aggregation were obtained under both circumstances (Figure 2a,b) . In addition, this method worked equally well for nanocrystals with other compositions (CdS/ZnS QDs and Au NPs) and morphologies (Fe−Pt nanorods (NRs) and Au−Fe 3 O 4 dimer nanoparticles (DNPs)) (Figure 2c−f) . A detailed synthesis procedure for these hydrophobic nanocrystals can be found in the SI. Therefore, the surface engineering Scheme 1. Strategy for One-Step Surface Engineering of Hydrophobic Nanocrystals with Designer Recognition a a Hydrophobic interactions between the surfactant ligands (purple) on the nanocrystal surface and the diacyllipids (blue) in the chimeric DNA molecules lead to spontaneous assembly, encapsulating individual nanocrystals inside the diacyllipid core and leaving the oligonucleotide (multi-color) corona outside to confer excellent water solubility and tunable molecular recognition. The molecular structure of the chimeric DNA molecule is shown at the bottom. method demonstrated here is independent of nanocrystal size, composition, and morphology. In addition, it is highly efficient with only a few empty micelles remaining ( Figure S7, SI) .
In order to determine their utility in biomedical applications, the stability of engineered nanocrystals was evaluated in various solution environments. No obvious aggregation was observed in water, phosphate buffered saline, or cell culture medium, even after more than 6 months.
After confirming the stability of functionalized nanocrystals in biological systems, we systematically investigated their ability to recognize desired molecular targets. First of all, the hybridization between modified nanocrystals and their cDNA (cDNA) was studied (Figure 3a Next, we tested the binding between modified nanocrystals and their target cancer cells, which is of great significance to their use in early cancer diagnosis and efficient cancer therapy. To accomplish this, Fe−Fe 3 O 4 CSNPs were functionalized with an FITC-labeled chimeric aptamer. Aptamers, generated from a process known as SELEX (Systematic Evolution of Ligands by EXponential enrichment), are single-stranded oligonucleotides which can bind to their targets with high affinity and excellent selectivity by folding into distinct secondary or tertiary structures. 18 An Sgc8 aptamer, 19 previously developed to specifically bind to CEM cells (T cell line, human acute lymphoblastic leukemia) using Ramos cells (B cell line, human Burkitt's lymphoma) as a control, was chosen for the study (Figure 4a ). According to flow cytometry histograms, an obvious shift (binding) was observed for CEM (target) cells, but only a negligible shift was noticed for Ramos (control) cells ( Figure  4b ). More importantly, even though much fewer engineered Fe− Fe 3 O 4 CSNPs (5 nM, 28 aptamers per functionalized nanoparticle) were used compared to free aptamers (200 nM), a much larger shift was achieved using modified Fe−Fe 3 O 4 CSNPs due to the multivalent effect. The affinity of a ligand to its receptor is highly dependent on its valency (the number of sites available for receptor attachment). Therefore, the presence of multiple aptamers on the surface of functionalized Fe−Fe 3 O 4 CSNPs resulted in greater cooperation, thereby enhancing the binding affinity to target cancer cells. With the FITC-labeled chimeric aptamer, the modified Fe−Fe 3 O 4 CSNPs can be used as specific fluorescence imaging agents with excellent sensitivity.
Magnetic resonance imaging (MRI) is one of the best noninvasive imaging modalities because of its ability to provide a large amount of spatial and temporal information using various contrast agents, especially iron oxide nanocrystals. 20−23 Therefore, we also tested the potential of using engineered Fe−Fe 3 O 4 CSNPs as T 2 (transverse relaxation time) contrast agents. Based on a self-amplifying proximity assay, 24 when multiple modified Compared to traditional polymer systems used to produce biocompatible nanocrystals from hydrophobic ones, like polyethylene glycol (PEG), the new method demonstrated here provides a more time-and labor-efficient single-step surface engineering approach: the DNA corona not only renders the functionalized nanoparticles with excellent water solubility but also furnishes them with tunable specific targeting. However, multiple steps are needed to accomplish the phase transfer of hydrophobic nanocrystals using traditional polymer systems, and additional procedures are further required for conjugating targeting ligands. In addition, without the necessity of a complicated organic synthesis, all these chimeric DNA molecules can be synthesized on a fully automated DNA/RNA synthesizer. If desired, different modifiers, including commercially available organic dyes, functional groups, therapeutic agents, or even short polymers (e.g., PEG), can be introduced at any location of the sequence during synthesis.
To summarize, we have developed a one-step facile surface engineering approach for hydrophobic nanocrystals using chimeric DNA molecules. This method is simple as well as efficient and can be readily adapted to a broad range of nanocrystals with variable size, composition, and morphology. Engineered nanocrystals possess excellent dispersity in biological fluids with minimal aggregation and long-term stability. In particular, this novel surface engineering approach equips modified nanocrystals with designer molecular recognition to various molecular addresses, varying from nucleic acids to cancer cells. Based on all these superior features, we believe that this newly developed surface engineering approach will greatly facilitate the use of nanocrystals in many biomedical applications. 
